We Are Binary Pharmaceuticals

Committed to quality, compliance, and global health outcomes.

“Am I a part of the cure? Or am I part of the disease?”

Coldplay — Clocks

Our Values


Binary Pharmaceuticals is a research-driven pharmaceutical organization committed to advancing science, improving patient outcomes, and delivering high-quality therapeutic solutions.

We focus on developing innovative products through rigorous scientific methods, strategic collaborations, and a commitment to integrity in everything we do.

Our work is guided by three core principles:

  • Scientific Excellence: We prioritize evidence-based research and uphold the highest standards of quality and accuracy.
  • Safety & Compliance: Our processes align with applicable industry and regulatory guidelines to ensure responsible development and distribution.
  • Global Impact: We aim to expand access to effective treatments and support healthier communities worldwide.

Binary Pharmaceuticals continues to evolve with a forward-thinking approach, expanding our capabilities while maintaining the ethical foundation that defines our organization.

Executive Board

Binary Pharma is guided by an experienced Board of Executives who provide strategic direction, oversight, and leadership across the organization.

Our board members bring decades of experience in pharmaceuticals, biotechnology, healthcare policy, and global business management.

Angela Sutterer

Angela Sutterer, PhD

CEO, Burke Therapeutics LLC

Dow Stough

Dowling B. Stough M.D.FAAD

Founder, The Dermatology Clinic

Pat Quinlan

Pat Quinlan M.D.

CEO, Hippo Technologies Inc

Burke Stough

Burke Stough, Esq

Corporate Attorney

Shaping the Future of Pharmaceutical Innovation

We are continuously refining our research, technologies, and processes to meet the ever-evolving needs of patients and partners around the world. Our vision is clear: deliver solutions that are safe, effective, and grounded in scientific excellence. Together, we can build a healthier tomorrow.